Literature DB >> 24865687

Cutaneous leishmaniasis in Cuban immigrants to Texas who traveled through the Darién Jungle, Panama.

Meagan A Barry1, Misha V Koshelev2, Grace S Sun2, Sarah J Grekin2, Charles E Stager2, A Hafeez Diwan2, Carina A Wasko2, Kristy O Murray2, Laila Woc-Colburn2.   

Abstract

Cutaneous leishmaniasis is rarely seen in the United States. Four Cuban immigrants traveled along the same route at different times from Cuba to Ecuador, then northward, including through the Darién Jungle in Panama. These patients had chronic ulcerative non-healing skin lesions and were given a diagnosis of leishmaniasis. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24865687      PMCID： PMC4125260          DOI： 10.4269/ajtmh.14-0124

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  14 in total

1.  U.S Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.

Authors:  J D Berman
Journal:  Clin Infect Dis       Date:  1999-01       Impact factor: 9.079

2.  The treatment of American (mucocutaneous) leishmaniasis with amphotericin B.

Authors:  S A SAMPAIO; J T GODOY; L PAIVA; N L DILLON; C S da LACAZ
Journal:  Arch Dermatol       Date:  1960-10

3.  Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis.

Authors:  Glenn Wortmann; Michael Zapor; Roseanne Ressner; Susan Fraser; Josh Hartzell; Joseph Pierson; Amy Weintrob; Alan Magill
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

4.  Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome.

Authors:  R Nonata; R Sampaio; P D Marsden
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Jan-Feb       Impact factor: 2.184

Review 5.  Mucosal leishmaniasis ("espundia" Escomel, 1911).

Authors:  P D Marsden
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

6.  Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis.

Authors:  M Brown; M Noursadeghi; J Boyle; R N Davidson
Journal:  Br J Dermatol       Date:  2005-07       Impact factor: 9.302

Review 7.  The epidemiology and control of leishmaniasis in Andean countries.

Authors:  C R Davies; R Reithinger; D Campbell-Lendrum; D Feliciangeli; R Borges; N Rodriguez
Journal:  Cad Saude Publica       Date:  2000 Oct-Dec       Impact factor: 1.632

8.  Short report epidemiologic studies on cutaneous leishmaniasis in eastern Panama.

Authors:  H A Christensen; A M de Vasquez; J L Petersen
Journal:  Am J Trop Med Hyg       Date:  1999-01       Impact factor: 2.345

Review 9.  Mucosal leishmaniasis . Current scenario and prospects for treatment.

Authors:  Valdir Sabbaga Amato; Felipe Francisco Tuon; Hélio Arthur Bacha; Vicente Amato Neto; Antonio Carlos Nicodemo
Journal:  Acta Trop       Date:  2007-08-19       Impact factor: 3.112

Review 10.  Cutaneous leishmaniasis treatment.

Authors:  Philippe Minodier; Philippe Parola
Journal:  Travel Med Infect Dis       Date:  2006-10-31       Impact factor: 6.211
View more
  9 in total

1.  In Vitro and In Vivo Characterization of Potent Antileishmanial Methionine Aminopeptidase 1 Inhibitors.

Authors:  Felipe Rodriguez; Sarah F John; Eva Iniguez; Sebastian Montalvo; Karina Michael; Lyndsey White; Dong Liang; Omonike A Olaleye; Rosa A Maldonado
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

2.  Cutaneous leishmaniasis and sand fly fluctuations are associated with el niño in panamá.

Authors:  Luis Fernando Chaves; José E Calzada; Anayansí Valderrama; Azael Saldaña
Journal:  PLoS Negl Trop Dis       Date:  2014-10-02

3.  Evaluation of IL-12RB1, IL-12B, CXCR-3 and IL-17a expression in cases affected by a non-healing form of cutaneous leishmaniasis: an observational study design.

Authors:  Mohammad Moafi; Hossein Rezvan; Roya Sherkat; Roya Taleban; Ali Asilian; Seyed Hamid Zarkesh Esfahani; Mohammad Ali Nilforoushzadeh; Fariba Jaffary; Awat Feizi
Journal:  BMJ Open       Date:  2017-01-27       Impact factor: 2.692

4.  TNF-α - 308 G/A and IFN-γ + 874 A/T gene polymorphisms in Saudi patients with cutaneous leishmaniasis.

Authors:  Ahmed A Ahmed; Zafar Rasheed; Tarek Salem; Mohammed S Al-Dhubaibi; Ahmad A Al Robaee; Abdullateef A Alzolibani
Journal:  BMC Med Genet       Date:  2020-05-13       Impact factor: 2.103

5.  COVID-19 pandemic in Panama: lessons of the unique risks and research opportunities for Latin America.

Authors:  Jose R Loaiza; Kosagisharaf Rao; Gilberto A Eskildsen; Eduardo Ortega-Barria; Matthew J Miller; Rolando A Gittens
Journal:  Rev Panam Salud Publica       Date:  2020-06-29

6.  Imported leishmaniasis cases in Cuba (2006-2016): what have we learned.

Authors:  Ana M Montalvo; Jorge Fraga; Orestes Blanco; Daniel González; Lianet Monzote; Lynn Soong; Virginia Capó
Journal:  Trop Dis Travel Med Vaccines       Date:  2018-08-07

7.  Development and Validation of a Sensitive, Specific and Reproducible UPLC-MS/MS Method for the Quantification of OJT007, A Novel Anti-Leishmanial Agent: Application to a Pharmacokinetic Study.

Authors:  Maria Rincon Nigro; Jing Ma; Ololade Tosin Awosemo; Huan Xie; Omonike Arike Olaleye; Dong Liang
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

Review 8.  Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021-A Comprehensive Review.

Authors:  Rafael Rocha; André Pereira; Carla Maia
Journal:  Pathogens       Date:  2022-08-16

Review 9.  The rise of neglected tropical diseases in the "new Texas".

Authors:  Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2018-01-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.